Been languishing as of late. Appears to be making a move. No news. Maybe Optiscan related?
It will be interesting to peruse the companies first and particularly second quarter results as it may be an indicator as to the effectiveness of the companies cost cutting measures and the much mooted high R an D spend and the new product lines resulting from that. A combination of cost cutting, measured R and D spend and new products/markets opening up may well be a good recipe or catalyst for improved, or even a significant improvement in profits into next year.
Maybe 2003 is the year when these measures will well and truly kick in.
